Status:

UNKNOWN

Role of Parecoxib Sodium for Postoperative Pain Management in Open Hepatectomy

Lead Sponsor:

Peking Union Medical College Hospital

Conditions:

Hepatic Hemangioma Located in the Right Liver

Laparotomy Surgery

Eligibility:

All Genders

20-70 years

Phase:

PHASE4

Brief Summary

To searching the role of parecoxib sodium for postoperative pain management in open hepatectomy

Eligibility Criteria

Inclusion

  • Age between 20-70 years old;
  • Hepatic hemangioma patients who will undergo laparotomy surgery: diameter of hepatic hemangioma between 5-15cm, located in the right liver;
  • Child score 5-6;
  • BMI: 19-25;
  • ASA: Ⅰ \~ Ⅱ grade;
  • No comorbidities such as diabetes, hypertension, cardio renal or respiratory dysfunction, mental illness;
  • No known allergies;
  • No participation in other clinical trials within 2 months;
  • Have been informed consent.
  • Surgery-related: right subcostal incision, surgical time\< 4 hours, hepatic pedicle occlusion time\< 20 minutes, bleeding\< 1000ml, no blood transfusions.

Exclusion

  • History of chronic pain,long-term use of analgesic drugs or alcohol abuse;
  • Allergic to NSAIDs, opioids or sulfa drugs;
  • Coagulopathy or other hematological disorder;
  • Active peptic ulcer, gastrointestinal bleeding, inflammatory bowel disease;
  • Pregnant or lactating;
  • Mentally unstable to use PCA;
  • Preoperative pain caused by other disease;
  • Analgesic drugs or NSAIDs intake one week before surgery;
  • Preoperative systemic inflammatory response syndrome;
  • Preoperative chemotherapy or radiotherapy;
  • Preoperative or postoperative use of steroids;
  • Operative time\> 4 hours, hepatic pedicle occlusion time\> 20 minutes, blood loss\> 1000ml, or intraoperative blood transfusion;
  • TBil\> 34 umol/L、PT prolongation\> 3S、ALB\< 30 g/L、or Child score\> 7 within 42 hours after surgery;
  • Bleeding、biliary fistula, intra-abdominal infections or other postoperative complications.

Key Trial Info

Start Date :

July 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT02204878

Start Date

July 1 2014

Last Update

July 30 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Peking union medical college hospital

Beijing, Beijing Municipality, China, 100032